PSTI breakout! Pluristem Therapeutics, Inc.
Jul 30, 2008 business, investing, trading
I’ve been waiting for this one for a while, and here it is folks. This is a Lebed pump, but it is a great company with virtually no debt and a low float of 4.75 million shares. Pluristem does adult stem cell research so they are not surrounded by controversy - and they have quite a few products that have yet to be put through phase trials or be approved by the FDA - but just wait, it will happen. Their stem cells they call “PLX” cells (PLacental eXpanded cells) have already successfully treated, for example, inflammatory bowel disease in rats. They have also completed successful pre-clinical trials in treating ischemic stroke.
Leave a Reply